HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 80 filers reported holding HARROW HEALTH INC in Q1 2022. The put-call ratio across all filers is 5.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,113 | -22.9% | 216,934 | +2.2% | 0.24% | -18.7% |
Q2 2023 | $4,040 | -41.7% | 212,198 | -35.2% | 0.29% | -39.9% |
Q1 2023 | $6,928 | -2.5% | 327,434 | -32.0% | 0.49% | -3.2% |
Q4 2022 | $7,108 | -99.9% | 481,618 | -30.6% | 0.50% | -21.5% |
Q3 2022 | $8,379,000 | +64.3% | 694,257 | -0.9% | 0.64% | +81.1% |
Q2 2022 | $5,100,000 | +47.0% | 700,637 | +37.7% | 0.36% | +74.0% |
Q1 2022 | $3,470,000 | -20.5% | 508,927 | +0.7% | 0.20% | -16.4% |
Q4 2021 | $4,364,000 | -4.6% | 505,154 | +0.4% | 0.24% | -13.2% |
Q3 2021 | $4,574,000 | -3.0% | 503,249 | -0.9% | 0.28% | +1.4% |
Q2 2021 | $4,715,000 | +39.4% | 507,602 | +1.3% | 0.28% | +27.6% |
Q1 2021 | $3,382,000 | -2.5% | 501,118 | -0.9% | 0.22% | -8.4% |
Q4 2020 | $3,469,000 | +124.5% | 505,746 | +82.9% | 0.24% | +119.4% |
Q3 2020 | $1,545,000 | +96.1% | 276,507 | +82.7% | 0.11% | +96.4% |
Q2 2020 | $788,000 | +33.1% | 151,305 | -2.4% | 0.06% | +22.2% |
Q1 2020 | $592,000 | -42.7% | 155,086 | +16.7% | 0.04% | -26.2% |
Q4 2019 | $1,033,000 | – | 132,840 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 3,140,000 | $29,171,000 | 4.84% |
Ophir Asset Management Pty Ltd | 1,670,817 | $15,522,000 | 2.73% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 378,389 | $3,515,000 | 1.16% |
Birchview Capital, LP | 180,000 | $1,672,000 | 1.00% |
Diametric Capital, LP | 82,443 | $766,000 | 0.55% |
Precision Wealth Strategies, LLC | 65,530 | $609,000 | 0.52% |
Uniplan Investment Counsel, Inc. | 507,602 | $4,715,000 | 0.28% |
BARD ASSOCIATES INC | 86,315 | $802,000 | 0.26% |
EAM Investors, LLC | 142,272 | $1,322,000 | 0.20% |
Zebra Capital Management LLC | 15,786 | $147,000 | 0.17% |